The U.S. home infusion therapy market demonstrated significant growth, reaching a size of USD 16.99 billion in 2023. This upward trajectory is expected to continue, with projections indicating the market will expand to USD 32.81 billion by 2033. Driven by a compound annual growth rate (CAGR) of 7.3% through the forecast period, the sector is poised for sustained advancement, reflecting increasing demand for convenient and effective healthcare solutions.
CONSIGNEE_NAME | SHIPPER_NAME | LOADING_PORT | UNLOADING_PORT | SUM OF QUANTITY | SUM OF WEIGHT |
CARGO PARTNER CHICAGO ILLINOI | DEGANIA MEDICAL DEVICES PRIVATE LIMITED | 53300, MANDVI | 1401, NORFOLK, VA | 485001329 | 143841 |
APS AMERICA LLC | ASAHI POLYSLIDER CO LIMITED | 58866, OSAKA | 3006, EVERETT, WA | 3304214 | 286340 |
FRESENIUS KABI USA | FRESENIUS KABI NORGE AS SVINESUNDSVEIEN | 42870, BREMERHAVEN | 1401, NORFOLK, VA | 3155526 | 630341 |
FISHER AND PAYKEL HEALTHCARE USA KY | FISHER AND PAYKEL HEALTHCARE LIMITED | 61443, TAURANGA | 1601, CHARLESTON, SC | 2805193 | 1359735 |
AUROLOGISTICS LLC | AUROBINDO PHARMA LIMITED | 53313, JAWAHARLAL NEHRU | 4601, NEW YORK/NEWARK AREA, NEWARK, NJ | 2575231 | 14938895 |
RB HEALTH US LLC | RECKITT BENCKISER HEALTHCARE UK LIMITED | 41251, LIVERPOOL | 4601, NEW YORK/NEWARK AREA, NEWARK, NJ | 2291566 | 2966062 |